RevBio, Inc.

Proud to be a member of the Boston Harbor Angels family of life science companies! Thanks BHA for highlighting RevBio's exciting advancements in the field of musculoskeletal health. To learn more about RevBio and TETRANITE's fast growing pipeline of head-to-toe indications, please visit our website: https://lnkd.in/et3gkWSy #RevBio #TETRANITE #TransformingBoneRepair #BoneAdhesive #Dental #Cranial #Trauma #Orthopaedics #FractureFixation #LifeSciences #Biomimetic #RegenerativeMedicine

It was an honor to attend the AMERICAN ACADEMY OF DENTAL SCIENCE (AADS) Spice Night?2024 held at Boston University last week. This event celebrated?the remarkable achievements of two distinguished members of?RevBio’s?Dental Clinical Advisory Board. We congratulate Dr. R. Bruce Donoff, MD, DMD, Professor and former Dean of Harvard University School of Dental Medicine, who was celebrated as an honorary fellow and awarded a Lifetime Achievement Award in recognition of his extraordinary contributions to the field of dentistry as a surgeon, educator, author, and researcher. Another congratulations to Dr. Alvaro Gracia, DDS, DMD, FICD, ABOI, FAAID, who?was formally inducted as the new president of the AADS. We are immensely proud of our esteemed advisors and extend our heartfelt congratulations to them for these well-deserved honors. To learn more about?RevBio’s?extensive board of Clinical Advisors, visit our website:?https://lnkd.in/g4XCraRc #RevBio #TETRANITE #BoneAdhesive #ClinicalAdvisors #DentalAdvisoryBoard #DentalScience #AADS #Biomaterials #RegenerativeMedicine #TransformingBoneRepair #DENTAL

It was a privilege to sponsor and attend the 5th Annual Health Data Science Symposium, hosted by Mass General Brigham (#MGB) Neurosurgery and the Computational Neuroscience Outcomes Center (#CNOC) at Harvard Medical School. This dynamic and insightful event brought together a diverse group of clinicians, industry leaders, academics, and students for a day filled with presentations, panels, and the latest scientific advancements at the intersection of neurosurgery and artificial intelligence (#AI). We extend our gratitude to our neurosurgical advisor, Dr. Timothy Smith, for organizing and hosting this engaging event.? ? A highlight of this year’s symposium was the presentation by Dr. Sourabh Boruah, Biomechanical Research Scientist at RevBio, who shared recent findings from research detecting?Volumetric Changes in Craniotomy Bone Flaps. This study, conducted in collaboration with CNOC, retrospectively analyzed CT data to evidence bone volume loss and lack of flap fusion following craniotomy procedures conducted with standard plates and screws.? ? In addition to Dr. Boruah’s presentation, attendees had the opportunity to learn about RevBio’s innovative regenerative bone adhesive,?TETRANITE, which is advancing how cranial flap fixation procedures may be conducted in the future. For more information on this innovative cranial flap clinical trial, visit our press release here:?https://lnkd.in/e237ZmQa #RevBio #TETRANITE #TETRANITEit #TransformingBoneRepair #RegnerativeMedicine #BoneAdhesive #LifeSciences #Biomimetic #Neurosurgery #Craniotomy #CranialFlapFixation #ClinicalTrial #Symposium #HMS #HarvardMedicalSchool

While in Memphis last week, the RevBio team visited the Semmes Murphey Clinic, one of two clinical trial sites for RevBio’s First-in-Human Cranial Flap Fixation Study, to build rapport with the clinical study team (pictured below) led by the study P.I., L. Madison Michael II, MD. Here, they celebrated the launch of this study where several patients have been successfully enrolled thus far with the TETRANITE bone adhesive. To learn more about this exciting ongoing clinical study, please read our press release here: https://shorturl.at/LnDcj Image 1, pictured (L-R): Jennifer Balink, Executive Director, Semmes Murphey Foundation (SMF) Sarah Lafferty, Clinical Research Coordinator, SMF Wendell Barnett, Senior Clinical Research Coordinator, SMF Courtney Berryman, Clinical Research Manage, SMF Sarah Moss, Study Monitor, PrimePath Medtech Brian Hess, RevBio CEO and Founder D. Grayson Allen, RevBio CFO/COO and Co-Founder Additionally, the team had the opportunity to collaborate with the Medical Education & Research Institute and to work with a couple members of RevBio's neuro-spinal surgical advisory board, including Alexander Dru M.D., to conduct a user handling trial to advance pre-clinical testing related to TETRANITE for spinal applications such as pedicle screw augmentation. We greatly appreciate their valuable feedback during the lab session. #RevBio #TETRANITE #TransformingBoneRepair #Cranial #CranialFlap #BrainSurgery #ClinicalTrials #SpinalFracture #TETRANITEit #BoneAdhesive #SemmesMurphey #ClinicalStudy #NovelProduct #Innovation

CEO Brian Hess and CFO D. Grayson Allen had a productive trip to Memphis, TN, last week for the 22nd Annual Musculoskeletal New Ventures Conference (MNVC). It was excellent to make new connections and gain insight on new developments in the Musculoskeletal industry. RevBio is proud to be among the 40 presenting companies, showcasing our innovative TETRANITE technology to conference attendees. A special thank you to Gary Stevenson for facilitating and organizing another great meeting at MNVC. #RevBio #TETRANITE #Musculoskeletal #health #BoneRepair #regenerativemedicine #innovation #breakthroughdevice #investor #regulatory #FDA #biomaterials

CEO Brian Hess and CFO D. Grayson Allen attended the 2024 The MedTech Conference in Toronto last week. It was a successful week forming meaningful connections with potential investors and collaborators, attending informative panel discussions, and checking out new and impressive advancements in the field of medical technology. As MedTech Innovator Alumni, it was fantastic to learn more about this year’s cohort of 65 startups during the MTI Showcase.? ? Thank you The MedTech Conference and AdvaMed for this excellent partnering opportunity. Looking forward to the next MedTech event! #MTC2024 #MedTechCon2024 #medtech #innovation #partneringevent #RevBio #TETRANITE #BoneAdhesive #investors #investmentopportunity #clinicalstage #biomaterials #MTI #MedTechInnovator

Looking forward to attending and presenting at the #MNVC2024 next week in Memphis, TN. See below for more information on next week's exciting agenda! #RevBio #TETRANITE #Musculoskeletal #health #BoneRepair #regenerativemedicine #innovation #breakthroughdevice #investor #regulatory #FDA #biomaterials

Continuing with our series, today’s letter is Q — for the Q3 Funding Report. Last week we released the Q3 Funding Report, which includes all Q1, Q2, and Q3 LSI Alumni deals, with nearly $900M raised across 55+ deals in Q3 alone. Through three quarters, we've seen increased investment across all Medtech and Healthtech verticals, and many new financing rounds across the LSI Alumni community. Altogether, LSI Alumni have raised over $2 billion in total capital through 120+ deals through 2024 thus far. View our spreadsheet with all the companies, deals, investors & more: https://lnkd.in/gzSb_tKX Here's a sneak peek of LSI Alumni featured in the Q3 report, many of whom attended LSI Europe '24 last month: ? AccuLine — Moshe Barel ? Affluent Medical — Sebastien Ladet, Ph.D. ? Bloomlife Inc — Eric Dy ? CairnSurgical, Inc. — Dave Danielsen ? Caresyntax — Bracy Fertig PhD ? Haermonics — Wouter Markus ? HEPTA Medical — Thomas Bancel ? Pylon Medical — Or Zigelboim ? RevBio, Inc. — Brian Hess ? SamanTree Medical SA — Olivier Delporte ? SpectraWAVE, Inc. — Eman Namati ? StarTric — Eugenio Passanante Congratulations to all those contributing to these milestones, pushing the boundaries of what's possible, and ultimately advancing patient care. Want to join LSI Alumni like these and hundreds of global strategics and investors for LSI USA '25 in Dana Point, California? Apply on our website today.

The ABCs of LSI Europe ‘24 — Today’s letter of the day is “R”. Here are the emerging Medtech and Healthtech companies who presented on stage that start with the letter R: ? R Group — Justin Ramsaran ? Radiance Therapeutics — Jessica Pan, MPH ? RECORNEA — Emiliano Lepore ? Resolve Stroke — Aritz Zamacola ? Restera Sleep (FKA Invicta Medical ) — Rick O'Connor ? Retia Medical — Marc Zemel ? RevBio, Inc. — Brian Hess ? ReVision Implant — Frederik Ceyssens ? Robeauté — Joana Cartocci ? Robocath — Philippe Bencteux MD ? Roivios, Ltd. — John Erbey Tune in each day as we recap LSI Europe ‘24 from A to Z. PS: Our 2025 event schedule is now set with three events across the globe: ? LSI USA '25: March 17th – 21st (Dana Point, CA) ? LSI Asia '25: June 10th – 13th (Singapore) ? LSI Europe '25: September 7th – 11th (London) Visit our website or connect with our team to secure your spot at the best rate for any of our 2025 events.

The 2024 The MedTech Conference kicks off next week in Toronto and RevBio is excited to attend for the 3rd year in a row! CEO Brian Hess and CFO D. Grayson Allen look forward to making meaningful connections at this years conference. This partnering event brings the world's leading innovators and executives from every part of the medtech industry together for 4 action-packed days of networking and collaboration. The MedTech conference is powered by AdvaMed Accel, the medtech association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. RevBio is proud to be a member of Advamed Accel since 2021. #MTC2024 #MedTechCon #medtech #technology #innovation #partnering #networking #healthcare #RevBio #TETRANITE #novel #products #boneadhesive #regenerativemedicine #investors